EuBiologics Co., Ltd.
(주)유바이오로직스
Verification summary
- Legal name (EN / KO)
- EuBiologics Co., Ltd. ((주)유바이오로직스)
- Business registration no.
211-88-40314(2118840314)- Stock listing
- KOSDAQ listed · stock code
206650· DART00927558 - 12-month KONEPS contracts
1contract · KRW 997,000,000- Live NTS tax status
- Check live NTS status ↗
- verified_at
How to verify a Korean company (BRN format, live NTS status, DART & KONEPS) →
- English name (as registered with DART)
- EuBiologics Co., Ltd.
- Korean legal name
- (주)유바이오로직스
- Alternate names
- 유바이오로직스
- Market
KOSDAQ- Stock Code
206650- DART Corp Code
00927558- CEO
- 백영옥,허태영(공동대표이사)
- Business Registration No.
211-88-40314- Corporate Registration No.
1101114294122- Established Date
2010-03-10- Fiscal Month
12- KSIC Industry Code
212- Address (KO)
- 서울특별시 강남구 도산대로 509 에스디바이오센서빌딩 13층, 14층, 15층
- Homepage
- https://www.eubiologics.com/ ↗
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
2026-11-01 04:28 UTCAnnual Financial Summary (KRW)
2025
Basis OFS (Separate)
Currency KRW
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 149,195,024,704 | KRW 96,035,297,831 |
| Operating Income (영업이익) | KRW 60,663,218,448 | KRW 34,321,335,803 |
| Net Income (당기순이익) | KRW 41,264,003,840 | KRW 18,991,722,463 |
| Total Assets (자산총계) | KRW 240,225,281,667 | KRW 202,084,808,067 |
| Total Liabilities (부채총계) | KRW 64,868,557,569 | KRW 70,052,296,606 |
| Total Equity (자본총계) | KRW 175,356,724,098 | KRW 132,032,511,461 |
2026-11-08 02:22 UTCRecent DART Filings (Last 90 Days, up to 20)
| Filed | Theme | Filing (EN) | Filer |
|---|---|---|---|
| No filings in the last 90 days. | |||
Data from Korea's Financial Supervisory Service (OpenDART). FSS does not guarantee accuracy or completeness. Figures as filed, in the currency shown (usually KRW). Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
2026-11-01 04:28 UTCPublic procurement (last 12 months)
Contracts first signed in the last 12 months.
The 12-month window is by original contract signing date: it covers contracts first signed in the period, and excludes amendments registered in the period to contracts signed earlier. Amounts are in KRW from Korea's Public Procurement Service (KONEPS). The 12-month total counts sole contracts in full and joint contracts by the supplier's share; joint contracts without a published share are counted but not summed. Multi-year contracts count only the current-period amount. Unit-price (framework) contracts are reported separately because their values are ceilings, not spend. Where KONEPS reports no total contract amount, the current-period amount is used as the total.
- Aggregation Period
2025-11-08to2026-11-07(basis:original_signed_date)- 12-Month Procurement Amount
- KRW 997,000,000
- 12-Month Contract Count
1(Joint contracts:0)- Unit-Price (Framework) Contracts (Reported Separately)
0contracts | Ceiling: KRW 0
By Procurement Category
| Category | Contracts | 12M Counted Amount (KRW) |
|---|---|---|
| Goods (물품) | 0 | KRW 0 |
| Construction (공사) | 0 | KRW 0 |
| Services (용역) | 1 | KRW 997,000,000 |
| Foreign Procurement (외자) | 0 | KRW 0 |
By Contract Type
| Contract Type | Contracts | Supplier Share / Current Amount (KRW) | Total Contract Ceiling / Multi-year Total (KRW) |
|---|---|---|---|
| Lump-sum / Standard (총액·일반) | 1 | KRW 997,000,000 | KRW 997,000,000 |
| Multi-year / Continuing (장기·계속비) | 0 | KRW 0 | KRW 0 |
| Unit-price / Framework Ceiling (단가·제3자단가 — excluded from 12M total) | 0 | KRW 0 | KRW 0 |
| Unclassified / Zero-amount (기타) | 0 | KRW 0 | KRW 0 |
Top 5 Government Buyers
| Buyer (Korean Legal Name) | Agency Code | Contracts | 12M Amount (KRW) |
|---|---|---|---|
| 질병관리청 국립보건연구원 | 1790399 | 1 | KRW 997,000,000 |
Recent Contracts (up to 1)
| Signed Date | Contract No. (KONEPS) | Contract Title (KO) | Category / Type | Buyer (KO) | Contract Amount (KRW) | Participation |
|---|---|---|---|---|---|---|
| 2026-04-24 | R26TA01788632 ↗ |
[학술] 니파바이러스 재조합 단백질 백신 후보물질 생산 세포주 특성 분석 및 GMP 생산 | services / lump_sum |
질병관리청 국립보건연구원 | KRW 997,000,000 | Sole (100%) |